Now showing items 1-10
Actinium-225 (2) |
Metastatic castration-resistant prostate cancer (mCRPC) (2) |
Prostate cancer (2) |
Prostate-specific membrane antigen (PSMA) (2) |
Bismuth-213 (1) |
Chemotherapy-naïve (1) |
Prostate-specific antigen (PSA) (1) |
PSMA-based alpha therapy (PAT) (1) |
Radioligand therapy (1) |
Targeted alpha therapy (1) |
Now showing items 1-10